Back to Glossary

    Patient Recruitment

    Patient Pre-screening

    Patient pre-screening is the process of evaluating individuals against a clinical trial's inclusion and exclusion criteria, before formal screening visits, to identify likely-eligible candidates and reduce screen failure rates.

    Pre-screening separates the small subset of likely-eligible patients from the much larger pool of theoretically interested ones. Done well, it dramatically lowers the per-randomized-patient cost; done poorly, it produces the industry-standard ~30; 50% screen failure rate that wastes site time and burns recruitment budget.

    Manual pre-screening means a coordinator reads physician notes, lab values, imaging reports, and medication lists for each potential participant. AI-powered pre-screening (Kitsa KScreener and similar tools) ingests structured and unstructured EHR data via FHIR, applies the protocol's criteria as code, and returns a ranked patient list with the supporting evidence quoted from each chart, so coordinators only review high-probability matches.

    Patient pre-screening is governed by HIPAA in the United States and GDPR Article 9 in the EU; both require either patient authorization or a covered preparatory-to-research basis to access PHI for eligibility evaluation.

    Related terms

    See how Kitsa applies this in your trials

    Kitsa's agentic AI compresses protocol development, site selection, and patient pre-screening from months into weeks.

    Request a demo